Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Infections, Staphylococcal

pyrroles has been researched along with Infections, Staphylococcal in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19903 (15.00)18.7374
1990's1 (5.00)18.2507
2000's1 (5.00)29.6817
2010's9 (45.00)24.3611
2020's6 (30.00)2.80

Authors

AuthorsStudies
Guo, B; Han, Y; Huang, Y; Mu, L; Zhao, X1
Li, C; Li, W; Li, Y; Ning, C; Tian, Y; Wang, X; Wong, TM; Xie, J; Xing, J; Yang, F; Yu, H; Yu, P; Zhang, H; Zhang, Z1
Fouche, G; Green, E; Mathiba, K; McGaw, L; Modimola, MS; Mthombeni, J; Njobeh, P; Nkadimeng, SM; Senabe, J1
Chen, Y; Hao, D; Jia, L; Ma, H; Sui, F; Wang, P; Xie, R; Yang, J; Yang, M; Yang, W; Zhao, H; Zhao, Q; Zhao, Y1
Akbari, N; Behzadpour, N; Sattarahmady, N1
Cao, B; Guo, X; Hu, X; Lu, S; Wang, C1
Bottiglieri, A; Ciani, F; Comite, E; De Filippis, A; De Martino, L; Gioia, L; Lorito, M; Nocera, FP; Staropoli, A; Tafuri, S; Vinale, F; Woo, SL1
Alm, R; Basarab, GS; Bist, S; Dangel, PB; Eakin, AE; Garner, CE; Green, O; Hauck, S; Hill, PJ; Hull, K; Illingworth, R; Manchester, JI; Rooney, M; Sherer, BA; Uria-Nickelsen, M; Zhou, F1
Brindha Devi, P; Janupally, R; Jeankumar, VU; Kulkarni, P; Medepi, B; Sriram, D; Suryadevara, P; Yogeeswari, P1
Barlow, R; Fehér, D; Hemscheidt, TK; McAtee, J1
Allocco, J; de la Cruz, M; Donald, RG; Dorso, K; Genilloud, O; Goetz, MA; Lee, S; Lu, J; Martín, J; Onishi, R; Overbye, K; Painter, RE; Phillips, JW; Polishook, J; Salowe, S; Sigmund, J; Singh, SB; Skwish, S; Smith, SK; Vicente, F; Wiltsie, J; Young, K; Zink, DL1
Andrews, B; Bist, S; Blodgett, A; Boriack-Sjodin, PA; Breeze, A; Bryant, J; Demeritt, J; Eakin, AE; Embrey, K; Gao, N; Green, O; Hales, N; Hauck, S; Hull, K; Illingworth, RN; Loch, JT; MacPherson, LJ; Mullen, G; Ni, H; Prince, B; Sherer, B; Singh, A; Timms, D; Uria-Nickelsen, M; Walkup, GK1
Hashizume, H1
Desplaces, N; Gabignon, C; Le Guyader, N; Lidove, O; Zeller, V; Ziza, JM1
Bauer, A; Brönstrup, M; Couturier, C; Dufour, C; Gerlitz, M; Heyse, W; Kogler, H; Kurz, M; Nußer, A; Olivan, H; Rey, A; Sablé, S; Toti, L; Wink, J1
Baird, EE; Bürli, RW; Duan, JX; Ge, Y; Gross, MI; Hu, W; Johnson, KW; Kaizerman, JA; Moser, HE; Tanaka, RD; White, S1
Adams, WJ; Allwine, DA; Emmert, DE; Ford, CW; Friis, JM; Garmon, SA; Genin, MJ; Hamel, JC; Hester, JB; Hutchinson, DK; Schaadt, RD; Shobe, EM; Stapert, D; Yagi, BH; Zurenko, GE1
Bailey, DM; Johnson, RE; Salvador, UJ1
Jaitly, KD; Kooreman, HJ; Marx, AF; van der Sijde, D1
Chisholm, DR; Godfrey, JC; Gourevitch, A; Misiek, M; Price, KE1

Reviews

1 review(s) available for pyrroles and Infections, Staphylococcal

ArticleYear
[Studies for the development of novel anti-MRSA/VRE drugs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Depsipeptides; Drug Discovery; Enterococcus; Glucosides; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Peptides, Cyclic; Polyisoprenyl Phosphates; Pyrroles; Staphylococcal Infections; Vancomycin Resistance

2012

Other Studies

19 other study(ies) available for pyrroles and Infections, Staphylococcal

ArticleYear
Bacterial Growth-Induced Tobramycin Smart Release Self-Healing Hydrogel for
    ACS nano, 2022, 08-23, Volume: 16, Issue:8

    Topics: Anti-Bacterial Agents; Antioxidants; Burns; Chitosan; Escherichia coli; Humans; Hydrogels; Polymers; Pseudomonas aeruginosa; Pyrroles; Staphylococcal Infections; Tobramycin; Wound Healing; Wound Infection

2022
Light-Programmable Nanocomposite Hydrogel for State-Switchable Wound Healing Promotion and Bacterial Infection Elimination.
    Advanced healthcare materials, 2023, Volume: 12, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Endothelial Cells; Humans; Hydrogels; Mice; Nanogels; Polymers; Pyrroles; Staphylococcal Infections; Wound Healing

2023
Investigating the Toxicity of Compounds Yielded by
    Toxins, 2022, Oct-18, Volume: 14, Issue:10

    Topics: Amines; Animals; Cattle; Chlorocebus aethiops; Female; Humans; Milk; Pyrroles; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Succinic Acid; Vero Cells

2022
Infection Microenvironment-Sensitive Photothermal Nanotherapeutic Platform to Inhibit Methicillin-Resistant Staphylococcus aureus Infection.
    Macromolecular bioscience, 2023, Volume: 23, Issue:2

    Topics: Anti-Bacterial Agents; Berberine; Biofilms; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymers; Pyrroles; Staphylococcal Infections

2023
Photothermal inactivation of methicillin-resistant
    IET nanobiotechnology, 2019, Volume: 13, Issue:8

    Topics: Anti-Bacterial Agents; Biofilms; Carbon; Coated Materials, Biocompatible; Hot Temperature; Humans; Materials Testing; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Nanocomposites; Phototherapy; Polymers; Pyrroles; Staphylococcal Infections

2019
In vivo photothermal inhibition of methicillin-resistant Staphylococcus aureus infection by in situ templated formulation of pathogen-targeting phototheranostics.
    Nanoscale, 2020, Apr-14, Volume: 12, Issue:14

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Cell Survival; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Nanoparticles; Oleic Acid; Photoacoustic Techniques; Photothermal Therapy; Polymers; Pyrroles; RAW 264.7 Cells; Staphylococcal Infections; Vancomycin

2020
Antimicrobial activity of harzianic acid against
    Natural product research, 2021, Volume: 35, Issue:23

    Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Hydroxybutyrates; Microbial Sensitivity Tests; Pyrroles; Staphylococcal Infections; Staphylococcus

2021
Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).
    Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14

    Topics: Adenosine Triphosphatases; Amides; Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Knockout; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrroles; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors

2014
Design and Biological Evaluation of Furan/Pyrrole/Thiophene-2-carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureus.
    Chemical biology & drug design, 2015, Volume: 86, Issue:4

    Topics: Animals; DNA Gyrase; Furans; Humans; Models, Molecular; Pyrroles; Staphylococcal Infections; Staphylococcus aureus; Thiophenes; Topoisomerase II Inhibitors; Zebrafish

2015
Highly brominated antimicrobial metabolites from a marine Pseudoalteromonas sp.
    Journal of natural products, 2010, Nov-29, Volume: 73, Issue:11

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Candida albicans; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Hydrocarbons, Brominated; Marine Biology; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phenols; Pseudoalteromonas; Pyrroles; Staphylococcal Infections; Staphylococcus aureus

2010
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.
    Chemistry & biology, 2011, Aug-26, Volume: 18, Issue:8

    Topics: Actinomycetales; Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Molecular; Pyrroles; Pyrrolidinones; Staphylococcal Infections; Staphylococcus aureus; Topoisomerase II Inhibitors

2011
Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agents.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Amides; Animals; Anti-Bacterial Agents; Binding Sites; Crystallography, X-Ray; DNA Gyrase; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Models, Molecular; Mutation; Protein Binding; Pyrroles; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Topoisomerase II Inhibitors

2012
[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
    La Revue de medecine interne, 2013, Volume: 34, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Creatine Kinase; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Prosthesis-Related Infections; Pyrroles; Rhabdomyolysis; Staphylococcal Infections

2013
Isolation and structural elucidation of armeniaspirols A-C: potent antibiotics against gram-positive pathogens.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2012, Dec-07, Volume: 18, Issue:50

    Topics: Anti-Bacterial Agents; Bacterial Structures; Biological Products; Crystallography, X-Ray; Drug Discovery; Gram-Positive Bacteria; Pyrroles; Spiro Compounds; Staphylococcal Infections; Staphylococcus aureus

2012
DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology.
    Journal of medicinal chemistry, 2003, Aug-28, Volume: 46, Issue:18

    Topics: Animals; Anti-Bacterial Agents; Distamycins; DNA; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Ligands; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Morpholines; Peritonitis; Pyrroles; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Toxicity Tests, Acute

2003
Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis.
    Journal of medicinal chemistry, 1998, Dec-17, Volume: 41, Issue:26

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Haemophilus influenzae; Inhibitory Concentration 50; Injections, Intravenous; Male; Mice; Moraxella catarrhalis; Oxazoles; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship

1998
Pyrrole antibacterial agents. 1. Compounds related to pyoluteorin.
    Journal of medicinal chemistry, 1973, Volume: 16, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Benzoates; Escherichia coli; Klebsiella Infections; Malaria; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Proteus vulgaris; Pseudomonas aeruginosa; Pyrroles; Schistosoma mansoni; Schistosomiasis; Staphylococcal Infections; Staphylococcus; Structure-Activity Relationship

1973
14Alpha, 17 alpha-alkylidenedioxy steroids. 2. 19-Nor-9 alpha, 10 beta- and 19-nor-9 beta, 10 alpha-progesterone analogs.
    Journal of medicinal chemistry, 1973, Volume: 16, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Carboxylic Acids; Escherichia coli; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Proteus vulgaris; Pseudomonas aeruginosa; Pyrroles; Staphylococcal Infections; Staphylococcus

1973
Semisynthetic coumermycins: structure-activity relationships.
    Applied microbiology, 1970, Volume: 19, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Klebsiella Infections; Mice; Pyrroles; Rats; Staphylococcal Infections

1970